(NASDAQ: SLGL) Sol Gel Technologies's forecast annual revenue growth rate of 11.74% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Sol Gel Technologies's revenue in 2025 is $11,707,000.On average, 1 Wall Street analysts forecast SLGL's revenue for 2025 to be $214,503,674, with the lowest SLGL revenue forecast at $214,503,674, and the highest SLGL revenue forecast at $214,503,674. On average, 1 Wall Street analysts forecast SLGL's revenue for 2026 to be $281,361,962, with the lowest SLGL revenue forecast at $281,361,962, and the highest SLGL revenue forecast at $281,361,962.
In 2027, SLGL is forecast to generate $476,365,302 in revenue, with the lowest revenue forecast at $476,365,302 and the highest revenue forecast at $476,365,302.